Molecular targets of the oncogenic transcription factor jun

Current Cancer Drug Targets

Volumn 3, Issue 1, 2003, Pages 41-55

  Hartl, M ^a   Bader, A G ^b   Bister, K ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; GENE REPRESSION; GENE TARGETING; HUMAN; NONHUMAN; ONCOGENE; ONCOGENE C JUN; ONCOGENE V JUN; PROTEIN FUNCTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, JUN; HUMANS; NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 12244311844     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033333781     Document Type: Article

References (175)

1. Maki, Y.; Bos, T. J.; Davis, C.; Starbuck, M.; Vogt, P. K. Avian Sarcoma Virus 17 Carries the jun Oncogene. Proc. Natl. Acad. Sci. USA 1987, 84, 2848-2852.
2. Wong, W.-Y.; Håvarstein, L. S.; Morgan, I. M.; Vogt, P. K. c-Jun Causes Focus Formation and Anchorage-Independent Growth in Culture but is Non-Tumorigenic. Oncogene 1992, 7, 2077-2080.
3. Hartl, M.; Vogt, P. K.; Bister, K. A Quail Long-term Cell Culture Transformed by a Chimeric jun Oncogene. Virology 1995, 207, 321-326.
4. Jurdic, P.; Treilleux, I.; Vandel, L.; Tabone, E.; Huguier, S.; Sergeant, A.; Castellazzi, M. Tumor Induction by v-Jun Homodimers in Chicken. Oncogene 1995, 11, 1699-1709.
5. Nishimura, T.; Vogt, P. K. The Avian Cellular Homolog of the Oncogenejun. Oncogene 1988, 3, 659-663.
6. rd; Cohen, D. R.; Curran, T.; Bos, T. J.; Vogt P. K.; Bohmann, D.; Tjian, R.; Franza, B. R. Jr. Fos-Associated Protein p39 is the Product of the jun Proto-Oncogene. Science 1988, 240, 1010-1016.
7. Sassone-Corsi, P.; Lamph, W. W.; Kamps, M.; Verma, I. M. fos-Associated Cellular p39 is Related to Nuclear Transcription Factor AP-1. Cell 1988, 54, 553-560.
8. Angel, P.; Allegretto, E. A.; Okino, S. T.; Hattori, K.; Boyle, W. J.; Hunter, T.; Karin, M. Oncogenejun Encodes a Sequence-Specific Trans-Activator Similar to AP-1. Nature 1988, 332, 166-171.
9. Bohmann, D.; Bos, T. J.; Admon, A.; Nishimura, T.; Vogt, P. K.; Tjian, R. Human Proto-Oncogene c-jun Encodes a DNA Binding Protein with Structural and Functional Properties of Transcription Factor AP-1. Science 1987, 238, 1386-1392.
10. Bos, T. J.; Bohmann, D.; Tsuchie, H.; Tjian, R.; Vogt P. K. v-jun Encodes a Nuclear Protein with Enhancer Binding Properties of AP-1. Cell 1988, 52, 705-712.
11. Angel, P.; Imagawa, M.; Chiu, R.; Stein, B.; Imbra, R. J.; Rahmsdorf, H. J.; Jonat, C.; Herrlich, P.; Karin, M. Phorbol Ester-Inducible Genes Contain a Common Cis Element Recognized by a TPA-Modulated Trans-Acting Factor. Cell 1987, 49, 729-739.
12. Lee, W.; Mitchell, P.; Tjian, R. Purified Transcription Factor AP-1 Interacts with TPA-Inducible Enhancer Elements. Cell 1987, 49, 741-752.
13. Vogt, P. K. Fortuitous Convergences: the Beginnings of JUN. Nat. Rev. Cancer 2002, 2, 465-469.
14. Angel, P.; Karin, M. The Role of Jun, Fos and the AP-1 Complex in Cell-Proliferation and Transformation. Biochim. Biophys. Acta 1991, 1072, 129-157.
15. Wisdom, R. AP-1: One Switch for Many Signals. Exp. Cell Res. 1999, 253, 180-185.
16. Vogt, P. K. Jun, the Oncoprotein. Oncogene 2001, 20, 2365-2377.
17. Shaulian, E.; Karin, M. AP-1 in Cell Proliferation and Survival. Oncogene 2001, 20, 2390-2400.
18. Jochum, W.; Passegué, E.; Wagner, E. F. AP-1 in Mouse Development and Tumorigenesis. Oncogene 2001, 20, 2401-2412.
19. van Dam, H.; Castellazzi, M. Distinct Roles of Jun: Fos and Jun: ATF Dimers in Oncogenesis. Oncogene 2001, 20, 2453-2464.
20. Mechta-Grigoriou, F.; Gerald, D.; Yaniv, M. The Mammalian Jun Proteins: Redundancy and Specificity. Oncogene 2001, 20, 2378-2389.
21. Ryder, K.; Lau, L. F.; Nathans, D. A Gene Activated by Growth Factors is Related to the Oncogene v-jun. Proc. Natl. Acad. Sci. USA 1988, 85, 1487-1491.
22. Hirai, S. I.; Ryseck, R. P.; Mechta, F.; Bravo, R.; Yaniv, M. Characterization of junD: a New Member of the jun Proto- Oncogene Family. EMBO J. 1989, 8, 1433-1439.
23. Hartl, M.; Hutchins, J.; Vogt, P. K. The Chicken junD Gene and its Product. Oncogene 1991, 6, 1623-1631.
24. Berger, I.; Shaul, Y. Structure and Function of Human jun-D. Oncogene 1991, 6, 561-566.
25. Cohen, D. R.; Curran, T. fra-1: a Serum-Inducible, Cellular Immediate-Early Gene that Encodes a fos-Related Antigen. Mol. Cell. Biol. 1988, 8, 2063-2069.
26. Nishina, H.; Sato, H.; Suzuki, T.; Sato, M.; Iba, H. Isolation and Characterization of fra-2, an Additional Member of the fos Gene Family. Proc. Natl. Acad. Sci. USA 1990, 87, 3619-3623.
27. Zerial, M.; Toschi, L.; Ryseck, R. P.; Schuermann, M.; Müller, R.; Bravo, R. The Product of a Novel Growth Factor Activated Gene, fos B, Interacts with JUN Proteins Enhancing their DNA Binding Activity. EMBO J. 1989, 8, 805-813.
28. Haluska, F. G.; Huebner, K.; Isobe, M.; Nishimura, T.; Croce, C. M.; Vogt, P. K. Localization of the Human JUN Protooncogene to Chromosome Region 1p31-32. Proc. Natl. Acad. Sci. USA 1988, 85, 2215-2218.
29. Morgan, I. M.; Ransone, L. J.; Bos, T. J.; Verma, I. M.; Vogt, P. K. Transformation by Jun: Requirement for Leucine Zipper, Basic Region and Transactivation Domain and Enhancement by Fos. Oncogene 1992, 7, 1119-1125.
30. Hartl, M.; Vogt, P. K. Oncogenic Transformation by Jun: Role of Transactivation and Homodimerization. Cell Growth Differ. 1992, 3, 899-908.
31. Basso, J.; Briggs, J.; Findlay, C.; Bos, T. Directed Mutation of the Basic Domain of v-Jun Alters DNA Binding Specificity and Abolishes its Oncogenic Activity in Chicken Embryo Fibroblasts. Oncogene 2000, 19, 4876-4885.
32. O'Shea, E. K.; Rutkowski, R.; Kim, P. S. Mechanism of Specificity in the Fos-Jun Oncoprotein Heterodimer. Cell 1992, 68, 699-708.
33. Glover, J. N. M.; Harrison, S. C. Crystal Structure of the Heterodimeric bZIP transcription Factor c-Fos-c-Jun Bound to DNA. Nature 1995, 373, 257-261.
34. Abate, C.; Patel, L.; Rauscher III, F. J.; Curran, T. Redox Regulation of Fos and Jun DNA-Binding Activity in vitro. Science 1990, 249, 1157-1161.
35. Oehler, T.; Pintzas, A.; Stumm, S.; Darling, A.; Gillespie, D.; Angel, P. Mutation of a Phosphorylation Site in the DNA-Binding Domain is Required for Redox-Independent Transactivation of AP1-Dependent Genes by v-Jun. Oncogene 1993, 8, 1141-1147.
36. Morgan, I. M.; Håtvarstein, L. S.; Wong, W.-Y.; Luu, P.; Vogt, P. K. Efficient Induction of Fibrosarcomas by v-Jun Requires Mutations in the DNA Binding Region and the Transactivation Domain. Oncogene 1994, 9, 2793-2797.
37. Xanthoudakis, S.; Curran, T. Identification and Characterization of Ref-1, a Nuclear Protein that Facilitates AP-1 DNA-Binding Activity. EMBO J. 1992, 11, 653-665.
38. Fritz, G.; Kaina, B. Phosphorylation of the DNA Repair Protein APE/REF-1 by CK11 Affects Redox Regulation of AP-1. Oncogene 1999, 18, 1033-1040.
39. Chida, K.; Vogt, P. K. Nuclear Translocation of Viral Jun but not of Cellular Jun is Cell Cycle Dependent. Proc. Natl. Acad. Sci. USA 1992, 89, 4290-4294.
40. Tagawa, T.; Kuroki, T.; Vogt, P. K.; Chida, K. The Cell Cycle-Dependent Nuclear Import of v-Jun is Regulated by Phosphorylation of a Serine Adjacent to the Nuclear Localization Signal. J. Cell. Biol. 1995, 130, 255-263.
41. Boyle, W. J.; Smeal, T.; Defize, L. H. K.; Angel, P.; Woodgett, J. R.; Karin, M.; Hunter, T. Activation of Protein Kinase C Decreases Phosphorylation of c-Jun at Sites that Negatively Regulate its DNA-Binding Activity. Cell 1991, 64, 573-584.
42. Derijard, B.; Hibi, M.; Wu, I. H.; Barrett, T.; Su, B.; Deng, T.; Karin, M.; Davis, R. J. JNKI: a Protein Kinase Stimulated by UV light and Ha-Ras that Binds and Phosphorylates the c-Jun Activation Domain. Cell 1994, 76, 1025-1037.
43. Bos, T. J.; Monteclaro, F. S.; Mitsunobu, F.; Ball, A. R. Jr.; Chang, C. H. W.; Nishimura, T.; Vogt, P. K. Efficient Transformation of Chicken Embryo Fibroblasts by c-Jun Requires Structural Modification in Coding and Noncoding Sequences. Genes Dev. 1990, 4, 1677-1687.
44. Hartl, M.; Reiter, F.; Bader, A. G.; Castellazzi, M.; Bister, K. JAC, a Direct Target of Oncogenic Transcription Factor Jun, is Involved in Cell Transformation and Tumorigenesis. Proc. Natl. Acad. Sci. USA 2001, 98, 13601-13606.
45. May, G. H.; Funk, M.; Black, E. J.; Clark, W.; Hussain, S.; Woodgett, J. R.; Gillespie, D. A. An Oncogenic Mutation Uncouples the v-Jun Oncoprotein from Positive Regulation by the SAPK/JNK Pathway in vivo. Curr. Biol. 1998, 8, 117-120.
46. Kovary, K.; Bravo, R. Existence of Different Fos/Jun Complexes During the G0-to-G1 Transition and During Exponential Growth in Mouse Fibroblasts: Differential Role of Fos Proteins. Mol. Cell. Biol. 1992, 12, 5015-5023.
47. Lallemand, D.; Spyrou, G.; Yaniv, M.; Pfarr, C. M. Variations in Jun and Fos Protein Expression and AP-1 Activity in Cycling, Resting and Stimulated Fibroblasts. Oncogene 1997, 14, 819-830.
48. Hughes, M.; Sehgal, A.; Hadman, M.; Bos, T. Heterodimerization with c-Fos is not Required for Cell Transformation of Chicken Embryo Fibroblasts by Jun. Cell Growth Differ. 1992, 3, 889-897.
49. Mölders, H.; Jenuwein, T.; Adamkiewicz, J.; Müller, R. Isolation and Structural Analysis of a Biologically Active Chicken c-fos cDNA: Identification of Evolutionarily Conserved Domains in fos Protein. Oncogene 1987, 1, 377-385.
50. van Dam, H.; Huguier, S.; Kooistra, K.; Baguet, J.; Vial, E.; van der Eb, A. J.; Herrlich, P.; Angel, P.; Castellazzi, M. Autocrine Growth and Anchorage Independence: Two Complementing Jun-Controlled Genetic Programs of Cellular Transformation. Genes Dev. 1998, 12, 1227-1239.
51. Hartl, M.; Bister, K. Structure and Transcriptional Regulation of BKJ, a Novel AP-1 Target Gene Activated During jun- or fos-Induced Fibroblast Transformation. Oncogene 1998, 17, 2901-2913.
52. Phillips, B. W.; Sharma, R.; Leco, P. A.; Edwards, D. R. A. Sequence-Selective Single-Strand DNA-Binding Protein Regulates Basal Transcription of the Murine Tissue Inhibitor of Metalloproteinases-1 (Timp-1) Gene. J. Biol. Chem. 1999, 274, 22197-2207.
53. Hawker, K. L.; Pintzas, A.; Hennigan, R. F.; Gillespie, D. A.; Ozanne, B. W. Transformation by the fos orjun Oncogene Does not Increase AP-1 DNA-Binding Activity. J. Virol. 1993, 67, 5487-5495.
54. Suzuki, T.; Murakami, M.; Onai, N.; Fukuda, E.; Hashimoto, Y.; Sonobe, M. H.; Kameda, T.; Ichinose, M.; Miki, K.; lba H. Analysis of AP-1 Function in Cellular Transformation Pathways. J. Virol. 1994, 68, 3527-3535.
55. Castellazzi, M.; Dangy, J. P.; Mechta, F.; Hirai, S.; Yaniv, M.; Samarut, J.; Lassailly, A.; Brun, G. Overexpression of Avian or Mouse c-jun in Primary Chick Embryo Fibroblasts Confers a Partially Transformed Phenotype. Oncogene 1990, 5, 1541-1547.
56. Gao, M.; Morgan, I.; Vogt, P. K. Differential and Antagonistic Effects of v-Jun and c-Jun. Cancer Res. 1996, 56, 4229-4235.
57. Lively, T. N.; Ferguson, H. A.; Galasinski; S. K.; Seto, A. G.; Goodrich, J. A. c-Jun Binds the N Terminus of Human TAF(II)250 to Derepress RNA polymerase II Transcription in vitro. J. Biol. Chem. 2001, 276, 25582-25588.
58. Arias, J.; Alberts, A. S.; Brindle, P.; Claret, F. X.; Smeal, T.; Karin, M.; Feramisco, J.; Montminy, M. Activation of cAMP and Mitogen Responsive Genes Relies on a Common Nuclear Factor. Nature 1994, 370, 226-229.
59. Moreau, A.; Yotov, W. V.; Glorieux, F. H.; St-Arnaud, R. Bone-Specific Expression of the Alpha Chain of the Nascent Polypeptide-Associated Complex, a Coactivator Potentiating c-Jun-Mediated Transcription. Mol. Cell. Biol. 1998, 18, 1312-1321.
60. Claret, F. X.; Hibi, M.; Dhut, S.; Toda, T.; Karin M. A New Group of Conserved Coactivators that Increase the Specificity of AP-1 Transcription Factors. Nature 1996, 383, 453-457.
61. Westermarck, J.; Weiss, C.; Saffrich, R.; Kast, J.; Musti, A. M.; Wessely, M.; Ansorge, W.; Seraphin, B.; Wilm, M.; Valdez, B. C.; Bohmann D. The DEAD/H-box RNA Helicase RHII/Gu is a Co-Factor for c-Jun-Activated Transcription. EMBO J. 2002, 21, 451-460.
62. Alani, R.; Brown, P.; Binétruy, B.; Dosaka, H.; Rosenberg, R.; Angel, P.; Karin, M.; Birrer, M. The Transactivating Domain of the c-Jun Proto-Oncoprotein is Required for Cotransformation of Rat Embryo Cells. Mol. Cell. Biol. 1991, 11, 6286-6295.
63. Hartl, M.; Vogt, P. K. A Rearranged JunD Transforms Chicken Embryo Fibroblasts. Cell Growth Differ. 1992, 3, 909-918.
64. Kameda, T.; Akahori, A.; Sonobe, M. H.; Suzuki, T.; Endo, T.; Iba, H. JunD Mutants with Spontaneously Acquired Transforming Potential Have Enhanced Transactivating Activity in Combination with Fra-2. Proc. Natl. Acad. Sci. USA 1993, 90, 9369-9373.
65. Struhl K. The JUN Oncoprotein, a Vertebrate Transcription Factor, Activates Transcription in Yeast. Nature 1988, 332, 649-650.
66. Håvarstein, L. S.; Morgan, I. M.; Wong, W. Y.; Vogt, P. K. Mutations in the Jun Delta Region Suggest an Inverse Correlation Between Transformation and Transcriptional Activation. Proc. Natl. Acad. Sci. USA 1992, 89, 618-622.
67. Gill, G.; Ptashne, M. Mutants of GAL4 Protein Altered in an Activation Function. Cell 1987, 51, 121-126.
68. Ma, J.; Ptashne, M. A New Class of Yeast Transcriptional Activators. Cell 1987, 51, 113-119.
69. Chinenov, Y.; Kerppola, T. K. Close Encounters of Many Kinds: Fos-Jun Interactions that Mediate Transcription Regulatory Specificity. Oncogene 2001, 20, 2438-2452.
70. Kataoka, K.; Noda, M.; Nishizawa, M. Maf Nuclear Oncoprotein Recognizes Sequences Related to an AP-1 Site and Forms Heterodimers with Both Fos and Jun. Mol. Cell. Biol. 1994, 14, 700-712.
71. Kataoka, K.; Shioda, S.; Yoshitomo-Nakagawa, K.; Handa, H.; Nishizawa, M. Maf and Jun Nuclear Oncoproteins Share Downstream Target Genes for Inducing Cell Transformation. J. Biol. Chem. 2001, 276, 36849-36856.
72. Aronheim, A.; Zandi, E.; Hennemann, H.; Elledge, S. J.; Karin M. Isolation of an AP-1 Repressor by a Novel Method for Detecting Protein-Protein Interactions. Mol. Cell. Biol. 1997, 17, 3094-3102.
73. Piu, F.; Aronheim, A.; Katz, S.; Karin, M. AP-1 Repressor Protein JDP-2: Inhibition of UV-Mediated Apoptosis through p53 Down-Regulation. Mol. Cell. Biol. 2001, 21, 3012-3024.
74. Yang-Yen, H. F.; Chambard, J. C.; Sun, Y. L.; Smeal, T.; Schmidt, T. J.; Drouin, J.; Karin, M. Transcriptional Interference between c-Jun and the Glucocorticoid Receptor: Mutual Inhibition of DNA Binding due to Direct Protein-Protein Interaction. Cell 1990, 62, 1205-1215.
75. Chen, L.; Glover, M. J. N.; Hogan, P. G.; Rao, A.; Harrison, S. C. Structure of the DNA-Binding Domains from NFAT, Fos and Jun Bound Specifically to DNA. Nature 1998, 392, 42-48.
76. Bassuk, A. G.; Leiden, J. M. A Direct Physical Association Between ETS and AP-1 Transcription Factors in Normal Human T Cells. Immunity 1995, 3, 223-237.
77. Martin, M. L.; Lieberman, P. M.; Curran, T. Fos-Jun Dimerization Promotes Interaction of the Basic Region with TFIIE-34 and TFIIF. Mol. Cell. Biol. 1996, 16, 2110-2118.
78. Antinore, M. J.; Birrer, M. J.; Patel, D.; Nader, L.; McCance, D. J. The Human Papillomavirus Type 16 E7 Gene Product Interacts with and Trans-Activates the AP-1 Family of Transcription Factors. EMBO J. 1996, 15, 1950-1960.
79. Bengal, E.; Ransone, L.; Scharfmann, R.; Dwarki, V. J.; Tapscott, S. J.; Weintraub, H.; Verma, I. M. Functional Antagonism between c-Jun and MyoD Proteins: a Direct Physical Association. Cell 1992, 68, 507-519.
80. Nead, M. A.; Baglia, L. A.; Antinore, M. J.; Ludlow, J. W.; McCance, D. J. Rb Binds c-Jun and Activates Transcription. EMBO J. 1998, 17, 2342-2352.
81. Monteclaro, F. S.; Vogt, P. K. A Jun-Binding Protein Related to a Putative Tumor Suppressor. Proc. Natl. Acad. Sci. USA 1993, 90, 6726-6730.
82. Imafuku, I.; Masaki, T.; Waragai, M.; Takeuchi, S.; Kawabata, M.; Hirai, S.; Ohno, S.; Nee, L. E.; Lippa, C. F.; Kanazawa, I.; Imagawa, M.; Okazawa, H. Presenilin 1 Suppresses the Function of c-Jun Homodimers via Interaction with QM/Jif-1. J. Cell. Biol. 1999, 147, 121-134.
83. Schuh, A. C.; Keating, S. J.; Yeung, M. C.; Breitman, M. L. Skeletal Muscle Arises as a Late Event during Development of Wound Sarcomas in v-jun Transgenic Mice. Oncogene 1992, 7, 667-676.
84. Su, H. Y.; Bos, T. J.; Monteclaro, F. S.; Vogt, P. K. Jun Inhibits Myogenic Differentiation. Oncogene 1991, 6, 1759-1766.
85. Li, L.; Chambard, J. C.; Karin, M.; Olson, E. N. Fos and Jun Repress Transcriptional Activation by Myogenin and MyoD: the Amino Terminus of Jun Can Mediate Repression. Genes Dev. 1992, 6, 676-689.
86. Karin, M.; Liu, Z.; Zandi, E. AP-1 Function and Regulation. Curr. Opin. Cell. Biol. 1997, 9, 240-246.
87. Johnson, R.; Spiegelman, B.; Hanahan, D.; Wisdom, R. Cellular Transformation and Malignancy Induced by Ras Require c-Jun. Mol. Cell. Biol. 1996, 16, 4504-4511.
88. Rapp, U. R.; Troppmair, J.; Beck, T.; Birrer, M. J. Transformation by Raf and Other Oncogenes Renders Cells Differentially Sensitive to Growth Inhibition by a Dominant Negative c-Jun Mutant. Oncogene 1994, 9, 3493-3498.
89. Clark, W.; Gillespie, D. A. Transformation by v-Jun Prevents Cell Cycle Exit and Promotes Apoptosis in the Absence of Serum Growth Factors. Cell Growth Differ. 1997, 8, 371-380.
90. MacLaren, A.; Clark, W.; Gillespie, D. A. v-Jun Sensitizes Cells to Apoptosis by a Mechanism Involving Mitochondrial Cytochrome C Release. Oncogene 2000, 19, 5906-5918.
91. Hilberg, F.; Aguzzi, A.; Howells, N.; Wagner E. F. c-Jun is Essential for Normal Mouse Development and Hepatogenesis. Nature 1993, 365, 179-181.
92. Johnson, R. S.; van Lingen, B.; Papaioannou, V. E.; Spiegelman, B. M. A Null Mutation at the c-jun Locus Causes Embryonic Lethality and Retarded Cell Growth in Culture. Genes Dev. 1993, 7, 1309-1317.
93. Schreiber, M.; Kolbus, A.; Piu, F.; Szabowski, A.; Möhle-Steinlein, U.; Tian, J.; Karin, M.; Angel, P.; Wagner, E. F. Control of Cell Cycle Progression by c-Jun is p53 Dependent. Genes Dev. 1999, 13, 607-619.
94. Schorpp-Kistner, M.; Wang, Z.-Q.; Angel, P.; Wagner, E. F. JunB is Essential for Mammalian Placentation. EMBO J. 1999, 18, 934-948.
95. Schreiber, M.; Wang, Z. Q.; Jochum, W.; Fetka, I.; Elliott, C.; Wagner, E. F. Placental Vascularisation Requires the AP-1 Component Fral. Development 2000, 127, 4937-4948.
96. Passegué, E.; Jochum, W.; Behrens, A.; Ricci, R.; Wagner, E. F. JunB can Substitute for Jun in Mouse Development and Cell Proliferation. Nat. Genet. 2002, 30, 158-166.
97. Schuh, A. C.; Keating, S. J.; Monteclaro, F. S.; Vogt, P. K.; Breitman, M. L. Obligatory Wounding Requirement for Tumorigenesis in v-jun Transgenic Mice. Nature 1990, 346, 756-760.
98. Grigoriadis, A. E.; Schellander, K.; Wang, Z. Q.; Wagner, E. F. Osteoblasts are Target Cells for Transformation in c-fos Transgenic Mice. J. Cell. Biol. 1993, 122, 685-701.
99. Clark, W.; Black, E. J.; MacLaren, A.; Kruse, U.; LaThangue, N; Vogt, P. K.; Gillespie D. A. v-Jun Overrides the Mitogen Dependence of S-Phase Entry by Deregulating Retinoblastoma Protein Phosphorylation and E2F-Pocket Protein Interactions as a Consequence of Enhanced Cyclin E-cdk2 Catalytic Activity. Mol. Cell. Biol. 2000, 20, 2529-2542.
100. Murakami, Y.; Ito, Y. Transcription Factors in DNA Replication. Front. Biosci. 1999, 4, D824-833.
101. Murakami, Y.; Satake, M.; Yamaguchi-Iwai, Y.; Sakai, M.; Muramatsu, M.; Ito, Y. The Nuclear Protooncogenes c-jun and c-fos as Regulators of DNA Replication. Proc. Natl. Acad. Sci. USA 1991, 88, 3947-3951.
102. Turner, W. J.; Woodworth, M. E. DNA Replication Efficiency Depends on Transcription Factor-Binding Sites. J. Virol. 2001, 75, 5638-5645.
103. Ito, K.; Asano, M.; Hughes, P.; Kohzaki, H.;Masutani, C.; Hanaoka, F.; Kerppola, T.; Curran, T.; Murakami, Y.; Ito, Y. c-Jun Stimulates Origin-Dependent DNA Unwinding by Polyomavirus Large T Antigen. EMBO J. 1996, 15, 5636-5646.
104. Suzuki, T.; Hashimoto, Y.; Okuno, H.; Sato, H.; Nishina, H.; Iba, H. High-Level Expression of Human c-jun Gene Causes Cellular Transformation of Chicken Embryo Fibroblasts. Jpn. J. Cancer Res. 1991, 82, 58-64.
105. Hartl, M.; Bister, K. Specific Activation in jun- transformed Avian Fibroblasts of a Gene (bkj) Related to the Avian β-Keratin Gene Family. Proc. Natl. Acad. Sci. USA 1995, 92, 11731-11735.
106. Schütte, J.; Minna, J. D.; Birrer, M. J. Deregulated Expression of Human c-jun Transforms Primary Rat Embryo Cells in Cooperation with an Activated c-Ha-ras Gene and Transforms Rat-1a Cells as a Single Gene. Proc. Natl. Acad. Sci. USA 1989, 86, 2257-2261.
107. Cohen, S. B.; Waha, A.; Gelman, I. H.; Vogt, P. K. Expression of a Down-Regulated Target, SSeCKS, Reverses v-Jun-Induced Transformation of 10T1/2 Murine Fibroblasts. Oncogene 2001, 20, 141-146.
108. Mann, B.; Gelos, M.; Siedow, A.; Hanski, M. L.; Gratchev, A.; Ilyas, M.; Bodmer, W. F.; Moyer, M. P.; Riecken, E. O.; Buhr, H. J.; Hanski, C. Target Genes of Beta-Catenin-T Cell-Factor/Lymphoid-Enhancer-Factor Signaling in Human Colorectal Carcinomas. Proc. Natl. Acad. Sci. USA 1999, 96, 1603-1608.
109. Mathas, S.; Hinz, M.; Anagnostopoulos, I.; Krappmann, D.; Lietz, A.; Jundt, F.; Bommert, K.; Mechta-Grigoriou, F.; Stein, H.; Dorken, B.; Scheidereit C. Aberrantly Expressed c-Jun and JunB are a Hallmark of Hodgkin Lymphoma Cells, Stimulate Proliferation and Synergize with NF-kappa B. EMBO J. 2002, 21, 4104-4113.
110. Gee, J. M.; Barroso, A. F.; Ellis, I. O.; Robertson, J. F.; Nicholson, R. I. Biological and Clinical Associations of c-jun Activation in Human Breast Cancer. Int. J. Cancer 2000, 89, 177-186.
111. Rinehart-Kim, J.; Johnston, M.; Birrer, M.; Bos, T. Alterations in the Gene Expression Profile of MCF-7 Breast Tumor Cells in Response to c-Jun. Int. J. Cancer 2000, 88, 180-190.
112. Smith, L. M.; Wise, S. C.; Hendricks, D. T.; Sabichi, A. L.; Bos, T.; Reddy, P.; Brown, P. H.; Birrer, M. J. cJun Overexpression in MCF-7 Breast Cancer Cells Produces a Tumorigenic, Invasive and Hormone Resistant Phenotype. Oncogene 1999, 18, 6063-6070.
113. Lu, A.; Gupta, A.; Li, C.; Ahlbom, T. E.; Ma, Y.; Shi, E. Y.; Liu, J. Molecular Mechanisms for Aberrant Expression of the Human Breast Cancer Specific Gene 1 in Breast Cancer Cells: Control of Transcription by DNA Methylation and Intronic Sequences. Oncogene 2001, 20, 5173-5185.
114. Liu, Y.; Ludes-Meyers, J.; Zhang, Y.; Munoz-Medellin, D.; Kim, H. T.; Lu, C.; Ge, G.; Schiff, R.; Hilsenbeck, S. G.; Osborne, C. K.; Brown, P. H. Inhibition of AP-1 Transcription Factor Causes Blockade of Multiple Signal Transduction Pathways and Inhibits Breast Cancer Growth. Oncogene 2002, 21, 7680-7689.
115. Angel, P.; Szabowski, A.; Schorpp-Kistner, M. Function and Regulation of AP-1 Subunits in Skin Physiology and Pathology. Oncogene 2001, 20, 2413-2423.
116. Oshima, R. G.; Baribault, H.; Caulin, C. Oncogenic Regulation and Function of Keratins 8 and 18. Cancer Metastasis Rev. 1996, 15, 445-471.
117. Young, M. R.; Li, J. J.; Rincón, M.; Flavell, R. A.; Sathyanarayana, B. K.; Hunziker, R.; Colburn, N. Transgenic Mice Demonstrate AP-1 (Activator Protein-1) Transactivation is Required for Tumor Promotion. Proc. Natl. Acad. Sci. USA 1999, 96, 9827-9832.
118. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H. Activator protein 1 (AP-1)- and Nuclear Factor κB (NF- κ B)-Dependent Transcriptional Events in Carcinogenesis. Free Radic. Biol. Med. 2000, 28, 1338-1348.
119. Saez, E.; Rutberg, S. E.; Mueller, E.; Oppenheim, H.; Smoluk, J.; Yuspa, S. H.; Spiegelman, B. M. c-fos is Required for Malignant Progression of Skin Tumors. Cell 1995, 82, 721-732.
120. Okuno, H.; Suzuki, T.; Yoshida, T.; Hashimoto, Y.; Curran, T.; Iba, H. Inhibition ofjun Transformation by a Mutated fos Gene: Design of an Anti-Oncogene. Oncogene 1991, 6, 1491-1497.
121. Li, J. J.; Cao, Y.; Young, M. R.; Colburn, N. H. Induced Expression of Dominant-Negative c-jun Downregulates NFkappaB and AP-1 Target Genes and Suppresses Tumor Phenotype in Human Keratinocytes. Mol. Carcinog. 2000, 29, 159-169.
122. Cochran, A. G. Antagonists of Protein-Protein Interactions. Chem. Biol. 2000, 7, R85-94.
123. Yang, G. Y.; Liao, J.; Li, C.; Chung, J.; Yurkow, E. J.; Ho, C. T.; Yang, C. S. Effect of Black and Green Tea Polyphenols on c-jun Phosphorylation and H(2)O(2) Production in Transformed and Non-Transformed Human Bronchial Cell Lines: Possible Mechanisms of Cell Growth Inhibition and Apoptosis Induction. Carcinogenesis 2000, 21, 2035-2039.
124. Balasubramanian, S.; Efimova, T.; Eckert, R. L. Green Tea Polyphenol Stimulates a RAS, MEKK1, MEK3, p38 Cascade to Increase AP1 Factor-Dependent Involucrin Gene Expression in Normal Human Keratinocytes. J. Biol. Chem. 2002, 277, 1828-1836.
125. Liu, G.; Bibus, D. M.; Bode, A. M.; Ma, W. Y.; Holman, R. T.; Dong, Z. Omega 3 but not Omega 6 Fatty Acids Inhibit AP-1 Activity and Cell Transformation in JB6 Cells. Proc. Natl. Acad. Sci. USA 2001, 98, 7510-7515.
126. Barthelman, M.; Chen, W.; Gensler, H. L.; Huang, C.; Dong, Z.; Bowden, G. T. Inhibitory Effects of Perillyl Alcohol on UVB-Induced Murine Skin Cancer and AP-1 Transactivation. Cancer Res. 1998, 58, 711-716.
127. Stratton, S. P.; Dorr, R. T.; Alberts, D. S. The State-of-the-Art in Chemoprevention of Skin Cancer. Eur. J. Cancer 2000, 36, 1292-1297.
128. Agadir, A.; Chen, G.; Bost, F.; Li, Y.; Mercola, D.; Zhang, X. Differential Effect of Retinoic Acid on Growth Regulation by Phorbol Ester in Human Cancer Cell Lines. J. Biol. Chem. 1999, 274, 29779-29785.
129. Huang, C.; Ma, W. Y.; Hanenberger, D.; Cleary, M. P.; Bowden, G. T.; Dong, Z. Inhibition of Ultraviolet B-Induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice. J. Biol. Chem. 1997, 272, 26325-26331.
130. Dong, Z.; Huang, C.; Brown, R. E.; Ma, W. Y. Inhibition of Activator Protein I Activity and Neoplastic Transformation by Aspirin. J. Biol. Chem. 1997, 272, 9962-9970.
131. Murono, S.; Yoshizaki, T.; Sato, H.; Takeshita, H.; Furukawa, M.; Pagano, J. S. Aspirin Inhibits Tumor Cell Invasiveness Induced by Epstein-Barr Virus Latent Membrane Protein 1 through Suppression of Matrix Metalloproteinase-9 Expression. Cancer Res. 2000, 60, 2555-2561.
132. Bennett, B. L.; Sasaki, D. T.; Murray, B. W.; O'Leary, E. C.; Sakata, S. T.; Xu, W.; Leisten, J. C.; Motiwala, A.; Pierce, S.; Satoh, Y.; Bhagwat, S. S.; Manning, A. M.; Anderson, D. W. SP600125, an Anthrapyrazolone Inhibitor of Jun N-Terminal Kinase. Proc. Natl. Acad. Sci. USA 2001, 98, 13681-13686.
133. Boyd, K. E.; Farnham, P. J. Identification of Target Genes of Oncogenic Transcription Factors. Proc. Soc. Exp. Biol. Med. 1999, 222, 9-28.
134. Hadman, M.; Gabos, L.; Loo, M.; Sehgal, A.; Bos, T. J. Isolation and Cloning of JTAP-1: a Cathepsin like Gene Upregulated in Response to V-Jun Induced Cell Transformation. Oncogene 1996, 12, 135-142.
135. Hadman, M.; Lin, W.; Bush, L.; Bos, T. J. Apolipoprotein A-1 is a Negative Target of v-Jun Overexpression. Oncogene 1998, 16, 655-660.
136. Goller, M. E.; Iacovoni, J. S.; Vogt, P. K.; Kruse, U. Glutaredoxin is a Direct Target of Oncogenic Jun. Oncogene 1998, 16, 2945-2948.
137. Fu, S.; Bottoli, I.; Goller, M.; Vogt, P. K. Heparin-Binding Epidermal Growth Factor-Like Growth Factor, a v-Jun Target Gene, Induces Oncogenic Transformation. Proc. Natl. Acad. Sci. USA 1999, 96, 5716-5721.
138. Bakin, A. V.; Curran, T. Role of DNA 5-Methylcytosine Transferase in Cell Transformation by fos. Science 1999, 283, 387-390.
139. Fu, S. L.; Waha, A.; Vogt, P. K. Identification and Characterization of Genes Upregulated in Cells Transformed by v-Jun. Oncogene 2000, 19, 3537-3545.
140. Bader, A. G; Schneider, M. L.; Bister, K.; Hartl, M. TOJ3, a Target of the v-Jun Transcription Factor, Encodes a Protein with Transforming Activity Related to Human Microspherule Protein 1 (MCRS1). Oncogene 2001, 20, 7524-7535.
141. Ozanne, B. W.; McGarry, L.; Spence, H. J.; Johnston, I.; Winnie, J.; Meagher, L.; Stapleton, G. Transcriptional Regulation of Cell Invasion: AP-1 Regulation of a Multigenic Invasion Programme. Eur. J. Cancer 2000, 36, 1640-1648.
142. Coller, H. A.; Grandori, C.; Tamayo, P.; Colbert, T.; Lander, E. S.; Eisenman, R. N.; Golub, T. R. Expression Analysis with Oligonucleotide Microarrays Reveals that MYC Regulates Genes Involved in Growth, Cell Cycle, Signaling, and Adhesion. Proc. Natl. Acad. Sci. USA 2000, 97, 3260-3265.
143. Neiman, P. E.; Ruddell, A.; Jasoni, C.; Loring, G.; Thomas, S. J.; Brandvold, K. A.; Lee, Rm.; Burnside, J.; Delrow, J. Analysis of Gene Expression During myc Oncogene-Induced Lymphomagenesis in the Bursa of Fabricius. Proc. Natl. Acad. Sci. USA 2001, 98, 6378-6383.
144. Kruse, U.; Iacovoni, J. S.; Goller, M. E.; Vogt, P. K. Hormone-Regulatable Neoplastic Transformation Induced by a Jun-Estrogen Receptor Chimera. Proc. Natl. Acad. Sci. USA 1997, 94, 12396-12400.
145. Bader, A. G.; Hartl, M.; Bister K. Conditional Cell Transformation by Doxycycline-Controlled Expression of the ASV17 v-jun Allele. Virology 2000, 270, 98-110.
146. Gossen, M.; Freundlieb, S.; Bender, G.; Müller, G.; Hillen, W.; Bujard, H. Transcriptional Activation by Tetracyclines in Mammalian Cells. Science 1995, 268, 1766-1769.
147. Kerr, L. D.; Holt, J. T.; Matrisian, L. M. Growth Factors Regulate Transin Gene Expression by c-fos-Dependent and c-fos-Independent Pathways. Science 1988, 242, 1424-1427.
148. Kim, H.; Pennie, W. D.; Sun, Y.; Colburn, N. H. Differential Functional Significance of AP-1 Binding Sites in the Promoter of the Gene Encoding Mouse Tissue Inhibitor of Metalloproteinases-3. Biochem. J. 1997, 324, 547-553.
149. Rauscher, F. J 3rd.; Sambucetti, L. C.; Curran, T.; Distel, R. J.; Spiegelman, B. M. Common DNA Binding Site for Fos Protein Complexes and Transcription factor AP-1. Cell 1988, 52, 471-480.
150. Lee, W.; Haslinger, A.; Karin, M.; Tjian R. Activation of Transcription by Two Factors that Bind Promoter and Enhancer Sequences of the Human Metallothionein Gene and SV40. Nature 1987, 325, 368-372.
151. Bergers, G.; Graninger, P.; Braselmann, S.; Wrighton, C.; Busslinger, M. Transcriptional Activation of the fra-1 Gene by AP-1 is Mediated by Regulatory Sequences in the First Intron. Mol. Cell. Biol. 1995, 15, 3748-3758.
152. Schüle, R.; Umesono, K.; Mangelsdorf, D. J.; Bolado, J.; Pike, J. W.; Evans, R. M. Jun-Fos and Receptors for Vitamins A and D Recognize a Common Response Element in the Human Osteocalcin Gene. Cell 1990, 61, 497-504.
153. Mauviel, A.; Korang, K.; Santra, M.; Tewari, D.; Uitto, J.; Iozzo, R. V. Identification of a Bimodal Regulatory Element Encompassing a Canonical AP-1 Binding Site in the Proximal Promoter Region of the Human Decorin Gene. J. Biol. Chem. 1996, 271, 24824-24829.
154. Welter, J. F.; Crish, J. F.; Agarwal, C.; Eckert, R. L. Fos-Related Antigen (Fra-1), junB, and junD Activate Human Involucrin Promoter Transcription by Binding to Proximal and Distal AP1 Sites to Mediate Phorbol Ester Effects on Promoter Activity. J. Biol. Chem. 1995, 270, 12614-12622.
155. DiSepio, D.; Jones, A.; Longley, M. A.; Bundman, D.; Rothnagel, J. A.; Roop, D. R. The Proximal Promoter of the Mouse Loricrin Gene Contains a Functional AP-1 Element and Directs Keratinocyte-Specific but not Differentiation-Specific Expression. J. Biol. Chem. 1995, 270, 10792-10799.
156. Casatorres, J.; Navarro, J. M.; Blessing, M.; Jorcano, J. L. Analysis of the Control of Expression and Tissue Specificity of the Keratin 5 Gene, Characteristic of Basal Keratinocytes. Fundamental Role of an AP-1 Element. J. Biol. Chem. 1994, 269, 20489-20496.
157. Oshima, R. G.; Abrams, L.; Kulesh, D. Activation of an Intron Enhancer within the Keratin 18 Gene by Expression of c-fos and c-jun in Undifferentiated F9 Embryonal Carcinoma Cells. Genes Dev. 1990, 4, 835-848.
158. Nishizawa, M.; Goto, N; Kawai, S. An Avian Transforming Retrovirus Isolated from a Nephroblastoma that Carries thefos Gene as Oncogene. J. Virol. 1987, 61, 3733-3740.
159. Eckert, R. L.; Crish, J. F.; Robinson, N. A. The Epidermal Keratinocyte as a Model for the Study of Gene Regulation and Cell Differentiation. Physiol. Rev. 1997, 77, 397-424.
160. Pankov, R.; Umezawa, A.; Maki, R.; Der, C. J.; Hauser, C. A.; Oshima, R. G. Oncogenic Activation of Human Keratin 18 Transcription via the Ras Signal Transduction Pathway. Proc. Natl. Acad. Sci, USA 1994, 91, 873-877.
161. Daily, D.; Vlamis-Gardikas, A.; Offen, D.; Mittelman, L.; Melamed, E.; Holmgren, A.; Barzilai, A. Glutaredoxin Protects Cerebellar Granule Neurons from Dopamine-Induced Apoptosis by Dual Activation of the Ras-Phosphoinositide 3-Kinase and Jun N-terminal Kinase Pathways. J. Biol. Chem. 2001, 276, 21618-21626.
162. McCarthy, S. A.; Chen, D.; Yang, B. S.; Garcia Ramirez, J. J.; Cherwinski, H.; Chen, X. R.; Klagsbrun, M.; Hauser, C. A.; Ostrowski, M. C.; McMahon, M. Rapid Phosphorylation of Ets-2 Accompanies Mitogen-Activated Protein Kinase Activation and the Induction of Heparin-Binding Epidermal Growth Factor Gene Expression by Oncogenic Raf-1. Mol. Cell. Biol. 1997, 17, 2401-2412.
163. Bruni, R.; Roizman, B. Herpes Simplex Virus 1 Regulatory Protein ICP22 Interacts with a New Cell Cycle-Regulated Factor and Accumulates in a Cell Cycle-Dependent Fashion in Infected Cells. J. Virol. 1998, 72, 8525-8531.
164. Ren, Y.; Busch, R. K.; Perlaky, L.; Busch, H. The 58-kDa Microspherule Protein (MSP58), a Nucleolar Protein, Interacts with Nucleolar Protein p120. Eur. J. Biochem. 1998, 253, 734-742.
165. Dang C. V. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism. Mol. Cell. Biol. 1999, 19, 1-11.
166. Slack, A.; Pinard, M.; Araujo, F. D.; Szyf, M. A Novel Regulatory Element in the dnmtl Gene that Responds to Co-Activation by Rb and c-Jun. Gene 2001, 268, 87-96.
167. Mettouchi, A.; Cabon, F.; Montreau, N.; Vernier, P.; Mercier, G.; Blangy, D.; Tricoire, H.; Vigier, P.; Binétruy, B. SPARC and
168. Vial, E.; Castellazzi, M. Down-Regulation of the Extracellular Matrix Protein SPARC in vSrc- and vJun- Transformed Chick Embryo Fibroblasts Contributes to Tumor Formation in vivo. Oncogene 2000, 19, 1772-1782.
169. Oberst, C.; Hartl, M.; Weiskirchen, R.; Bister, K. Conditional Cell Transformation by Doxycycline-Controlled Expression of the MC29 v-myc Allele. Virology 1999, 253, 193-207.
170. Vial, E.; Perez, S.; Castellazzi, M. Transcriptional Control of SPARC by v-Jun and Other Members of the AP1 Family of Transcription Factors. Oncogene 2000, 19, 5020-5029.
171. Dejong, V.; Degeorges, A.; Filleur, S.; Ait-Si-Ali, S.; Mettouchi, A.; Bornstein, P.; Binétruy, B.; Cabon, F. The Wilms' Tumor Gene Product Represses the Transcription of Thrombospondin 1 in Response to Overexpression of c-Jun. Oncogene 1999, 18, 3143-3151.
172. Hanahan, D.; Weinberg R. A. The Hallmarks of Cancer. Cell 2000, 100, 57-70.
173. Ideker, T.; Vesteinn, T.; Ranish, J. A.; Christmas, R.; Buhler, J.; Eng, J. K.; Bumgarner, R.; Goodlett, D. R.; Aebersold, R.; Hood, L. Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network. Science 292, 929-934.
174. Somogyi, R.; Greller, L. D. The Dynamics of Molecular Networks: Applications to Therapeutic Discovery. Drug Discov. Today 2001, 6, 1267-1277.
175. Tyson, J. J.; Chen, K.; Novak, B. Network Dynamics and Cell Physiology. Nature Reviews 2001, 2, 908-916.